Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

[1]  E. Crawford,et al.  Advanced prostate cancer , 1999, Prostate Cancer and Prostatic Diseases.

[2]  A. Patchefsky,et al.  Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA <10 ng/ml treated with conformal external beam radiation therapy. , 1998, International journal of radiation oncology, biology, physics.

[3]  M. Piérart,et al.  Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. , 1997, The New England journal of medicine.

[4]  A. Hanlon,et al.  Conformai external beam treatment of prostate cancer , 1997 .

[5]  A. Hanlon,et al.  Early stage prostate cancer treated with radiation therapy: stratifying an intermediate risk group. , 1997, International journal of radiation oncology, biology, physics.

[6]  H. Sandler,et al.  Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[7]  D. Grignon,et al.  Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  T E Schultheiss,et al.  Optimization of conformal radiation treatment of prostate cancer: report of a dose escalation study. , 1997, International journal of radiation oncology, biology, physics.

[9]  David J. Sheskin,et al.  Handbook of Parametric and Nonparametric Statistical Procedures , 1997 .

[10]  A. Hanlon,et al.  1003 Accounting for competing risks is essential in comparing surgery and radiation treatment of prostate cancer , 1997 .

[11]  T. Schultheiss,et al.  116 Initial results of using daily CT localization to correct portal error in prostate cancer , 1997 .

[12]  A. Hanlon,et al.  Rectal bleeding after conformal 3D treatment of prostate cancer: time to occurrence, response to treatment and duration of morbidity. , 1997, International journal of radiation oncology, biology, physics.

[13]  A. Hanlon,et al.  Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. , 1997, International journal of radiation oncology, biology, physics.

[14]  T E Schultheiss,et al.  Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 NG/ML. , 1996, International journal of radiation oncology, biology, physics.

[15]  T E Schultheiss,et al.  Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect. , 1996, International journal of radiation oncology, biology, physics.

[16]  D. Grignon,et al.  Conformal mixed neutron and photon irradiation in localized and locally advanced prostate cancer: preliminary estimates of the therapeutic ratio. , 1996, International journal of radiation oncology, biology, physics.

[17]  G Starkschall,et al.  Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. , 1996, International journal of radiation oncology, biology, physics.

[18]  C. Orton,et al.  Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study. , 1996, International journal of radiation oncology, biology, physics.

[19]  H. Sandler.  3-D conformal radiotherapy for prostate cancer. The University of Michigan experience. , 1996, Frontiers of radiation therapy and oncology.

[20]  H. Sandler,et al.  Three dimensional conformal radiotherapy for the treatment of prostate cancer: low risk of chronic rectal morbidity observed in a large series of patients. , 1995, International journal of radiation oncology, biology, physics.

[21]  C. Ling,et al.  The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. , 1995, The cancer journal from Scientific American.

[22]  G. Hanks.  A question-filled future for dose-escalation in prostate cancer--regarding Shipley et al., IJROBP 32:3-12; 1995. , 1995, International journal of radiation oncology, biology, physics.

[23]  L. Verhey,et al.  Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. , 1995, International journal of radiation oncology, biology, physics.

[24]  G. Hanks.  A question-filled future for dose escalation in prostate cancer. , 1995, International journal of radiation oncology, biology, physics.

[25]  W. R. Lee,et al.  2 Conformal technique dose escalation in prostate cancer: improved cancer control with higher doses in patients with pretreatment PSA 10 ngm/ml , 1995 .

[26]  M. Zelefsky,et al.  Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase 1 dose-escalation study. , 1994, The Journal of urology.

[27]  R Mohan,et al.  Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study. , 1994, International journal of radiation oncology, biology, physics.

[28]  H. Sandler,et al.  Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  C B Begg,et al.  The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. , 1991, International journal of radiation oncology, biology, physics.

[30]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[31]  G. Hanks.  ASTRO 1984 Presidential Address. Optimizing the radiation treatment and outcome of prostate cancer. , 1984, International journal of radiation oncology, biology, physics.

[32]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[33]  D. Cox.  Regression Models and Life-Tables , 1972 .

[34]  N. Mantel.  Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[35]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .